Israeli Pharma gets FDA Approval for Asthma Antibody
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
How patients use CINQAIR® (reslizumab) Injection Cost Support Program Card
CINQAIR® (reslizumab) Injection – About Asthma Control
Drug Analysis: Cinqair - Research and Markets
CINQAIR® (reslizumab) Injection – About Asthma Control
Cinqair (reslizumab)- Asthma- by Saro Arakelians, PharmD- Episode # 123 - YouTube
Cinqair: Package Insert - Drugs.com
Reslizumab | New Drug Approvals
Cinqair Reslizumab Injection
CINQAIR® (reslizumab) Injection – About Asthma Control
New Drug Product: Cinqair - MPR
CINQAIR® (reslizumab) Injection – About Asthma Control
including co-pays, co-insurance, and deductibles.*
FDA Approves Cinqair To Treat Severe Asthma - Pharmacy Practice News
Teva gets EU nod for severe asthma drug Cinqaero - PMLiVE
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
Clinical Efficacy Guidelines
761033Orig1s000
Medication Detail
Attachment: Product Information: Reslizumab
A program supporting CINQAIR® (reslizumab) Injection patients
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
